Paul Tudor Jones Rx Sight, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 31,469 shares of RXST stock, worth $956,342. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,469
Previous 83,116
62.14%
Holding current value
$956,342
Previous $5 Million
68.91%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding RXST
# of Institutions
225Shares Held
32.2MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$119 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$69.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$53.1 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$35.6 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $840M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...